
The FDA has granted Ocular Systems Inc. (OS) 501(K) clearance to market its human corneal endothelium delivery instrument, the EndoSerter. For use during endothlelial keratoplasty, this instrument delivers a corneal endothelail allograft less than or equal to 8.5 mm in diameter and less than or equal to 175 micrograms in central thickness through a single 4-mm incision.


.png)


